Private company
SR ONE CAPITAL MANAGEMENT, LLC
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
SR ONE CAPITAL MANAGEMENT, LLC sits at the top of its group. 10 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SR ONE CAPITAL MANAGEMENT, LLC
- Simeon John George Owns 25% to 50% of Sr One Capital Management, LLC, since 10/2019 (Form ADV)
- Rajeev Nmn Dadoo Owns 25% to 50% of Sr One Capital Management, LLC, since 10/2019 (Form ADV)
- SR ONE CAPITAL MANAGEMENT, LLC DE
- ADARx Pharmaceuticals, Inc. Stake · San Diego, California
- Arcellx, Inc. Stake · Redwood City, California
- Avalyn Pharma Inc. Stake · Boston, Massachusetts
- eFFECTOR Therapeutics, Inc. Stake · San Diego, California, United States
- Kala Pharmaceuticals (United States) Stake · Waltham
- Odyssey Therapeutics, Inc. Stake · Boston, Massachusetts
- Oric Pharmaceuticals, Inc. Stake · San Francisco, California, United States
- Veradermics, Inc Stake · New Haven, Connecticut
- Zenas BioPharma, Inc. Stake · Waltham, Massachusetts
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (9 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.
Investment adviser
SR ONE CAPITAL MANAGEMENT, LLC is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.
- Assets it manages$2.4B2 19 accounts, all with discretion
- Employees28 15 in investment advice or research
- ClientsPooled investment vehicles (other than investment companies and: 19 ($2.4B)
- How it is paidA percentage of assets under its management; Performance-based fees
- What it doesPortfolio management for pooled investment vehicles (other than investment companies)
- Holds client assetsYes: cash and securities
- RegistrationSEC 801-119142, CRD 306361 IAPD record
Who owns it
Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).
- Rajeev Nmn Dadooowns 25% to 50%, since 10/2019
- Simeon John Georgeowns 25% to 50%, since 10/2019
- Simeon John Georgeowns 75% or more of SR ONE CAPITAL, since 10/2019
Stakes it holds
SR ONE CAPITAL MANAGEMENT, LLC has told the SEC it owns more than 5% of 9 companies, latest first (Schedules 13D and 13G).
- ADARx Pharmaceuticals, Inc.SCHEDULE 13D Oct 5, 20263
- Zenas BioPharma, Inc.SCHEDULE 13D/A Sep 23, 2024 to Aug 17, 20264
- Veradermics, IncSCHEDULE 13D/A Feb 11, 2026 to Aug 14, 20265
- Odyssey Therapeutics, Inc.SCHEDULE 13D May 18, 20266
- Avalyn Pharma Inc.SCHEDULE 13D May 8, 20267
- Kala Pharmaceuticals (United States)SCHEDULE 13D/A Jul 8, 2024 to Oct 15, 20258
- Oric Pharmaceuticals, Inc.SCHEDULE 13D/A Jun 5, 2025 to Aug 14, 20259
- Arcellx, Inc.SC 13D/A Feb 17, 2022 to Mar 25, 202410
- eFFECTOR Therapeutics, Inc.SC 13G/A Feb 14, 2022 to Feb 9, 202411
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11